Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
+11.3M
-
Total reported value, excl. options
-
$36.9M
-
Value change
-
+$26M
-
Put/Call ratio
-
3.78
-
Number of buys
-
18
-
Number of sells
-
-9
-
Price
-
$2.30
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q4 2022
36 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q4 2022.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 153M outstanding shares and own 10.47% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (6.09M shares), Birchview Capital, LP (5.04M shares), Worth Venture Partners, LLC (1.5M shares), VANGUARD GROUP INC (1.11M shares), WELLS FARGO & COMPANY/MN (774K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (378K shares), Cannell & Co. (206K shares), HighTower Advisors, LLC (136K shares), GEODE CAPITAL MANAGEMENT, LLC (126K shares), and Endurant Capital Management LP (124K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.